An in Vitro Assay of hERG K+ Channel Potency for a New EGFR Inhibitor FHND004 | |
Jin, Tao; Hu, Bingxue; Chen, Shanshan; Wang, Qiang; Dong, Xue; Zhang, Yin; Zhu, Yongqiang; Zhang, Zhao | |
刊名 | FRONTIERS IN PHARMACOLOGY |
2018 | |
卷号 | 9 |
关键词 | FHND004 EGFR inhibitor human ether-a-go-go-related gene inhibitory effect cardiac safety |
ISSN号 | 1663-9812 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3603218 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Jin, Tao,Hu, Bingxue,Chen, Shanshan,et al. An in Vitro Assay of hERG K+ Channel Potency for a New EGFR Inhibitor FHND004[J]. FRONTIERS IN PHARMACOLOGY,2018,9. |
APA | Jin, Tao.,Hu, Bingxue.,Chen, Shanshan.,Wang, Qiang.,Dong, Xue.,...&Zhang, Zhao.(2018).An in Vitro Assay of hERG K+ Channel Potency for a New EGFR Inhibitor FHND004.FRONTIERS IN PHARMACOLOGY,9. |
MLA | Jin, Tao,et al."An in Vitro Assay of hERG K+ Channel Potency for a New EGFR Inhibitor FHND004".FRONTIERS IN PHARMACOLOGY 9(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论